Citation 148400

DIRCH,VM: STUPPNER,H: ELLMERER-MULLER,EP: VOLLMAR,AM:. (2000). STRUCTURAL REQUIREMENTS OF SESQUITERPENE LACTONES TO INHIBIT LPS-INDUCED NITRIC OXIDE SYNTHESIS IN RAW 264.7 MACROPHAGES.. 8(12)

Citation Details

Title	STRUCTURAL REQUIREMENTS OF SESQUITERPENE LACTONES TO INHIBIT LPS-INDUCED NITRIC OXIDE SYNTHESIS IN RAW 264.7 MACROPHAGES.
Authors	DIRCH,VM: STUPPNER,H: ELLMERER-MULLER,EP: VOLLMAR,AM:
Year	2000
Volume	8
Issue	12

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMBROSIN	ACTIVE
2	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AMBROSIN	INACTIVE
3	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIPINNATIN	ACTIVE
4	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIPINNATIN	INACTIVE
5	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELENALIN	ACTIVE
6	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HELENALIN	INACTIVE
7	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARTHENIN,1-EPI:	ACTIVE
8	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PARTHENIN,1-EPI:	INACTIVE
9	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAILLARDIN	ACTIVE
10	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GAILLARDIN	ACTIVE
11	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALANTOLACTONE	ACTIVE
12	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALANTOLACTONE	INACTIVE
13	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLAUCOLIDE A	ACTIVE
14	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLAUCOLIDE A	INACTIVE
15	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TAXINIC ACID BETA-D-GLUCOSYL ESTER	INACTIVE
16	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSILOSTACHYIN	ACTIVE
17	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSILOSTACHYIN	INACTIVE
18	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSILOTROPIN	ACTIVE
19	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PSILOTROPIN	ACTIVE
20	NITRIC OXIDE SYNTHESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHATIN	ACTIVE
21	NUCLEAR FACTOR KAPPA-BETA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XANTHATIN	INACTIVE

Citation 148400

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1